Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Cooper

Showing results (311-320 of 363) with videos related to

Pageof 37
Sort By:
Ophthalmology|April 12, 2001
Macular pigment optical density in a midwestern sampleT A Ciulla, J Curran-Celantano, D A Cooper, et al.
Domestic Animal Endocrinology|April 1, 1993
Factors contributing to the formation of experimentally-induced ovarian cysts in prepubertal giltsJ A Hall, E M Meisterling, A M Benoit, et al.
AIDS (London, England)|February 19, 1998
Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects. Community HIV Research Network InvestigatorsA D Kelleher, M Roggensack, A B Jaramillo, et al.
AIDS Research and Human Retroviruses|January 1, 1997
Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injectionA D Kelleher, S Emery, P Cunningham, et al.
The New England Journal of Medicine|August 17, 1995
A controlled trial of zidovudine in primary human immunodeficiency virus infectionS Kinloch-De Loës, B J Hirschel, B Hoen, et al.
HIV Medicine|December 14, 2011
Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled studyA Winston, R Puls, S J Kerr, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 30, 1999
Kaposi's sarcoma-associated herpesvirus: a sexually transmissible infection?A E Grulich, S J Olsen, K Luo, et al.
The Journal of Infectious Diseases|August 19, 2000
Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infectionD Smith, M M Berrey, M Robertson, et al.
AIDS (London, England)|October 1, 1996
Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: the Australian AIDS cohortG J Dore, Y Li, A E Grulich, et al.
The New England Journal of Medicine|July 29, 1993
Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative GroupD A Cooper, J M Gatell, S Kroon, et al.
Pageof 37

Showing results (311-320 of 363) with videos related to

Sort By:
Pageof 37
Ophthalmology|April 12, 2001
Macular pigment optical density in a midwestern sampleT A Ciulla, J Curran-Celantano, D A Cooper, et al.
Domestic Animal Endocrinology|April 1, 1993
Factors contributing to the formation of experimentally-induced ovarian cysts in prepubertal giltsJ A Hall, E M Meisterling, A M Benoit, et al.
AIDS (London, England)|February 19, 1998
Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects. Community HIV Research Network InvestigatorsA D Kelleher, M Roggensack, A B Jaramillo, et al.
AIDS Research and Human Retroviruses|January 1, 1997
Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injectionA D Kelleher, S Emery, P Cunningham, et al.
The New England Journal of Medicine|August 17, 1995
A controlled trial of zidovudine in primary human immunodeficiency virus infectionS Kinloch-De Loës, B J Hirschel, B Hoen, et al.
HIV Medicine|December 14, 2011
Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled studyA Winston, R Puls, S J Kerr, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 30, 1999
Kaposi's sarcoma-associated herpesvirus: a sexually transmissible infection?A E Grulich, S J Olsen, K Luo, et al.
The Journal of Infectious Diseases|August 19, 2000
Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infectionD Smith, M M Berrey, M Robertson, et al.
AIDS (London, England)|October 1, 1996
Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: the Australian AIDS cohortG J Dore, Y Li, A E Grulich, et al.
The New England Journal of Medicine|July 29, 1993
Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative GroupD A Cooper, J M Gatell, S Kroon, et al.
Pageof 37